Metabolic engineering of Saccharomyces cerevisiae for production of very long chain fatty acid-derived chemicals
Authors/Creators
- 1. Department of Biology and Biological Engineering, Chalmers University of Technology, Kemiva¨gen 10, Gothenburg SE-41296, Sweden. Novo Nordisk Foundation Center for Biosustainability, Chalmers University of Technology, Gothenburg SE-41296, Sweden.
- 2. Department of Biology and Biological Engineering, Chalmers University of Technology, Kemiva¨gen 10, Gothenburg SE-41296, Sweden. Novo Nordisk Foundation Center for Biosustainability, Chalmers University of Technology, Gothenburg SE-41296, Sweden. Biopetrolia AB, Systems and Synthetic Biology Group, Chalmers University of Technology, Kemiva¨gen 10, Gothenburg SE-41296, Sweden
- 3. Department of Biology and Biological Engineering, Chalmers University of Technology, Kemiva¨gen 10, Gothenburg SE-41296, Sweden. Novo Nordisk Foundation Center for Biosustainability, Chalmers University of Technology, Gothenburg SE-41296, Sweden. Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens Lyngby DK-2800, Denmark. Science for Life Laboratory, Royal Institute of Technology, Stockholm SE-17121, Sweden.
Description
Production of chemicals and biofuels through microbial fermentation is an economical and sustainable alternative for traditional chemical synthesis. Here we present the construction of a Saccharomyces cerevisiae platform strain for high-level production of very-long-chain fatty acid (VLCFA)-derived chemicals. Through rewiring the native fatty acid elongation system and implementing a heterologous Mycobacteria FAS I system, we establish an increased biosynthesis of VLCFAs in S. cerevisiae. VLCFAs can be selectively modified towards the fatty alcohol docosanol (C22H46O) by expressing a specific fatty acid reductase. Expression of this
enzyme is shown to impair cell growth due to consumption of VLCFA-CoAs. We therefore implement a dynamic control strategy for separating cell growth from docosanol production. We successfully establish high-level and selective docosanol production of 83.5 mg l1 in yeast. This approach will provide a universal strategy towards the production of similar high value chemicals in a more scalable, stable and sustainable manner.
Files
Metabolic engineering of Saccharomyces.pdf
Files
(689.7 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:0d2eee65a14354efc103eca226472d66
|
689.7 kB | Preview Download |